Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.
about
Vascular Ageing and Exercise: Focus on Cellular Reparative ProcessesRole of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectivesVitreous mediators in retinal hypoxic diseasesEffect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus ResolutionDespite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient miceImpact of obesity control on circulating level of endothelial progenitor cells and angiogenesis in response to ischemic stimulationQuantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancerExpression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes.Synergistic effect of vaginal trauma and ovariectomy in a murine model of stress urinary incontinence: upregulation of urethral nitric oxide synthases and estrogen receptors.Period2 deficiency blunts hypoxia-induced mobilization and function of endothelial progenitor cells.Zoledronate inhibits ischemia-induced neovascularization by impairing the mobilization and function of endothelial progenitor cellsNanofiber Microenvironment Effectively Restores Angiogenic Potential of Diabetic Endothelial Cells.Myocardium-derived conditioned medium improves left ventricular function in rodent acute myocardial infarction.Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients.Dysfunctional endothelial progenitor cells in metabolic syndromeA review of the pathophysiology and potential biomarkers for peripheral artery disease.Knockdown of transient receptor potential canonical-1 reduces the proliferation and migration of endothelial progenitor cells.Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice.Cardiac shockwave therapy improves myocardial function in patients with refractory coronary artery disease by promoting VEGF and IL-8 secretion to mediate the proliferation of endothelial progenitor cells.Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient miceMicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation.Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds.Endothelial progenitor cells in atherosclerosis.tPA-MMP-9 Axis Plays a Pivotal Role in Mobilization of Endothelial Progenitor Cells from Bone Marrow to Circulation and Ischemic Region for Angiogenesis.Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients.Coordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice.Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.Reactive oxygen species in vascular formation and development.The angiogenic gene profile of circulating endothelial progenitor cells from ischemic stroke patientsStimulatory Influences of Far Infrared Therapy on the Transcriptome and Genetic Networks of Endothelial Progenitor Cells Receiving High Glucose TreatmentAndrogen receptor (AR) promotes male bladder cancer cell proliferation and migration via regulating CD24 and VEGFMatrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodelingPivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.Migration and fate of therapeutic stem cells in different brain disease models.Endothelial progenitor cells and integrins: adhesive needs.Experimental approaches to vascularisation within tissue engineering constructs.Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.SCF/C-KIT signaling modulates tryptase expression in acute myeloid leukemia cells.Response of the cerebral vasculature following traumatic brain injury.
P2860
Q26772296-CB57436B-8E94-4D9B-83B3-6A94E523F380Q26824706-8D7AAE21-8CF5-4110-B68D-56B8A27E7D83Q27028225-3FCABD0C-CE41-4525-9711-C0FCD00CE27BQ27333560-1B6B2B82-A9E4-4AD7-AF63-E710CA9DA430Q28548467-87D0F65F-A7AB-4C46-8735-54A3462633A1Q30358598-13DA3627-448C-42AF-833B-F64830171D4EQ31061249-292F64E2-95FB-4755-8CCB-6F2BA7B87F99Q33803176-BB1F1C22-8C89-464B-9AD3-86612BF00E15Q33944710-7D97397A-0475-45EE-9C45-8EA8690F82D3Q34199176-486045B4-B2B6-4D1F-9004-052B0DD3F505Q34277673-C044ADA2-7047-4F42-A274-6D3FEBF8BC9FQ34358196-561FDBB1-334C-42B4-BB61-F59A9B047B1EQ34440104-3D705BC9-C68B-4AC0-845B-273F14B24366Q34552638-9BD4D1F9-9654-49B6-9072-4B82E45D4038Q34576771-E83452AC-2B25-4CA1-88CD-9E2782203390Q35222376-8A227D0E-B430-4391-9B4F-990AA28382AFQ35723731-283BA3E3-9D5C-46EB-BBDE-011EF535F669Q35737474-6DAFD53A-6A9D-42D5-8EBA-C9955F5AD081Q35759361-3345B660-CDA5-4375-9F79-B4E9A1714FB3Q35868953-B72B1B05-77BC-46CC-8F2C-326FDB45D2E7Q35870375-FE5493B1-7616-4632-9A52-1589C4A14C47Q35901547-642E06A2-C8E5-43B2-951D-5FA4888B54A6Q35995364-15FD2C3A-AC87-4AC6-90FC-648E3D8BB7F7Q36011477-69464FC9-691F-41AB-B143-BE0D28B6D505Q36127644-FAA78759-42DE-49AB-B2E3-BA82D99FBDABQ36150527-AE804011-4D44-4BA7-AFA1-096C649A5C0DQ36216091-FF42F19A-E70D-4710-8700-302AE9C47612Q36320266-7D38FF49-1ED9-43BB-BD0C-32FA917B163BQ36587602-1945BB7B-D651-415F-8F41-504A8FF7DD05Q36643126-F7E479CD-FD85-4BC0-8D7A-0D538040959BQ36721202-DE136584-B604-4964-8796-38468B1B5AADQ36841172-F716517A-59C5-4A9C-96DB-5DB7B6D06BBDQ36960275-44542A41-AA7E-4CE2-9B67-D49D2FC108E2Q37549578-C822EAB5-FE44-42BF-B019-87F31D14FEBCQ37938466-A1FFB2B9-84DB-4362-8A13-6D9BE295FF1DQ37992761-ED574912-5921-42E9-B803-0677197079B4Q38520494-6095AA3A-EE3D-4F26-8F63-6986E8FCA2A4Q38522829-E4508202-64DB-4A7E-8A90-32AAC98F6B1BQ38997341-8ACE7E3A-E31A-4180-B33F-346D991BDB8CQ39221209-B01D0997-FBBC-40AC-9593-DBC6B7398329
P2860
Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Matrix metalloproteinase-9 is ...... endothelial progenitor cells.
@ast
Matrix metalloproteinase-9 is ...... endothelial progenitor cells.
@en
type
label
Matrix metalloproteinase-9 is ...... endothelial progenitor cells.
@ast
Matrix metalloproteinase-9 is ...... endothelial progenitor cells.
@en
prefLabel
Matrix metalloproteinase-9 is ...... endothelial progenitor cells.
@ast
Matrix metalloproteinase-9 is ...... endothelial progenitor cells.
@en
P2093
P921
P1476
Matrix metalloproteinase-9 is ...... endothelial progenitor cells.
@en
P2093
Chao-Hung Wang
Feng-Yen Lin
Hsiao-Ya Tsai
Jaw-Wen Chen
Jia-Shiong Chen
Masataka Sata
Po-Hsun Huang
Shing-Jong Lin
Tao-Cheng Wu
Wei-Yuh Lo
P304
P356
10.1161/ATVBAHA.109.189175
P407
P577
2009-05-21T00:00:00Z